Compare · TMO vs XPON
TMO vs XPON
Side-by-side comparison of Thermo Fisher Scientific Inc (TMO) and Expion360 Inc. (XPON): market cap, price performance, sector, and recent activity on the wire.
Summary
- TMO operates in Industrials, while XPON operates in Miscellaneous - the two are in different parts of the market.
- TMO is the larger of the two at $222.97B, about 41746.2x XPON ($5.3M).
- XPON has been more active in the news (19 items in the past 4 weeks vs 13 for TMO).
- TMO has more recent analyst coverage (25 ratings vs 0 for XPON).
- Company
- Thermo Fisher Scientific Inc
- Expion360 Inc.
- Price
- -
- -
- Market cap
- $222.97B
- $5.3M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NASDAQ
- IPO
- 2022
- News (4w)
- 13
- 19
- Recent ratings
- 25
- 0
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Expion360 Inc.
Expion360 Inc. designs, assembles, manufactures, and sells lithium iron phosphate batteries and supporting accessories under the VPR 4EVER name for recreational vehicles, marine, golf, industrial, residential, and off-the-grid applications. It also provides various models of industrial tiedowns; battery monitors; terminal blocks; and bus bars. The company also engages in the development of e360 Home Energy Storage systems. It serves dealers, wholesalers, and original equipment manufacturers in the United States and internationally. The company was formerly known as Yozamp Products Company, LLC and changed its name to Expion360 Inc. in November 2021. Expion360 Inc. was founded in 2016 and is headquartered in Redmond, Oregon.
Latest TMO
- CLSA initiated coverage on Thermo Fisher with a new price target
- Executive Vice President Shafer Michael D covered exercise/tax liability with 790 shares, decreasing direct ownership by 4% to 20,204 units (SEC Form 4)
- SVP and General Counsel Shropshire Thomas B Jr. covered exercise/tax liability with 49 shares, decreasing direct ownership by 0.81% to 6,008 units (SEC Form 4)
- Sr. VP and Chief HR Officer Britt Lisa P. covered exercise/tax liability with 394 shares, decreasing direct ownership by 3% to 14,391 units (SEC Form 4)
- Sr. Vice President & CFO Meyer James covered exercise/tax liability with 270 shares, decreasing direct ownership by 5% to 5,560 units (SEC Form 4)
- Chairman & CEO Casper Marc N covered exercise/tax liability with 1,257 shares, decreasing direct ownership by 1% to 122,669 units (SEC Form 4)
- VP & Chief Accounting Officer Holmes Joseph R. covered exercise/tax liability with 50 shares, decreasing direct ownership by 2% to 2,916 units (SEC Form 4)
- President & COO Pettiti Gianluca covered exercise/tax liability with 1,035 shares, sold $2,539,233 worth of shares (4,133 units at $614.38) as part of a pre-agreed trading plan and exercised 3,733 shares at a strike of $309.63, decreasing direct ownership by 6% to 23,216 units (SEC Form 4)
- Thermo Fisher Scientific to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026
- Chairman & CEO Casper Marc N exercised 275 shares at a strike of $309.63 and sold $172,439 worth of shares (275 units at $627.05) as part of a pre-agreed trading plan (SEC Form 4)
Latest XPON
- SEC Form D filed by Expion360 Inc.
- SEC Form PRE 14A filed by Expion360 Inc.
- Chief Executive Officer Sellers Kevin was granted 50,000 shares (SEC Form 4)
- Chief Financial Officer Winspear Robert L was granted 30,000 shares (SEC Form 4)
- SEC Form 3 filed by new insider Sellers Kevin
- SEC Form 3 filed by new insider Winspear Robert L
- Expion360 Inc. filed SEC Form 8-K: Leadership Update, Shareholder Director Nominations, Regulation FD Disclosure, Financial Statements and Exhibits
- Expion Energy Adds Veteran Oil and Gas Executive Marc Jarvis to Board of Directors
- Expion Energy Appoints Robert Winspear as Chief Financial Officer
- Director Shum Steve was granted 5,000 shares, increasing direct ownership by 571% to 5,876 units (SEC Form 4)